Two Sigma Advisers’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-249,600
| Closed | -$260K | – | 2362 |
|
|
2024
Q3 | $260K | Buy |
249,600
+38,000
| +18% | +$39.5K | ﹤0.01% | 1971 |
|
|
2024
Q2 | $366K | Buy |
211,600
+4,500
| +2% | +$7.79K | ﹤0.01% | 1997 |
|
|
2024
Q1 | $495K | Sell |
207,100
-27,000
| -12% | -$64.5K | ﹤0.01% | 1872 |
|
|
2023
Q4 | $780K | Buy |
234,100
+208,400
| +811% | +$694K | ﹤0.01% | 1746 |
|
|
2023
Q3 | $96.1K | Sell |
25,700
-44,500
| -63% | -$166K | ﹤0.01% | 2213 |
|
|
2023
Q2 | $300K | Sell |
70,200
-24,100
| -26% | -$103K | ﹤0.01% | 1982 |
|
|
2023
Q1 | $645K | Sell |
94,300
-122,500
| -57% | -$838K | ﹤0.01% | 1835 |
|
|
2022
Q4 | $1.72M | Buy |
216,800
+40,200
| +23% | +$318K | ﹤0.01% | 1315 |
|
|
2022
Q3 | $1.7M | Buy |
176,600
+75,200
| +74% | +$723K | ﹤0.01% | 1252 |
|
|
2022
Q2 | $734K | Buy |
101,400
+24,800
| +32% | +$180K | ﹤0.01% | 1747 |
|
|
2022
Q1 | $989K | Buy |
+76,600
| New | +$989K | ﹤0.01% | 1643 |
|
|
2020
Q3 | – | Sell |
-235,200
| Closed | -$4.2M | – | 2425 |
|
|
2020
Q2 | $4.2M | Sell |
235,200
-123,900
| -35% | -$2.21M | 0.01% | 866 |
|
|
2020
Q1 | $5.83M | Sell |
359,100
-33,600
| -9% | -$545K | 0.02% | 655 |
|
|
2019
Q4 | $7.07M | Buy |
392,700
+133,400
| +51% | +$2.4M | 0.02% | 713 |
|
|
2019
Q3 | $5.25M | Buy |
259,300
+68,100
| +36% | +$1.38M | 0.01% | 741 |
|
|
2019
Q2 | $4.23M | Buy |
191,200
+150,900
| +374% | +$3.34M | 0.01% | 898 |
|
|
2019
Q1 | $550K | Buy |
40,300
+8,900
| +28% | +$121K | ﹤0.01% | 1757 |
|
|
2018
Q4 | $284K | Sell |
31,400
-11,700
| -27% | -$106K | ﹤0.01% | 2010 |
|
|
2018
Q3 | $711K | Buy |
43,100
+6,500
| +18% | +$107K | ﹤0.01% | 1651 |
|
|
2018
Q2 | $512K | Buy |
+36,600
| New | +$512K | ﹤0.01% | 1906 |
|
|
2017
Q1 | – | Sell |
-23,700
| Closed | -$667K | – | 2349 |
|
|
2016
Q4 | $667K | Buy |
23,700
+13,100
| +124% | +$369K | ﹤0.01% | 1730 |
|
|
2016
Q3 | $284K | Buy |
+10,600
| New | +$284K | ﹤0.01% | 1898 |
|